Gabapentin Tablet, Film Coated
Product Images NDC 80425-0158

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0158). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1

A line graph titled 'Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1'. It compares mean pain scores over 8 weeks between a placebo group and a Gabapentin 3600 mg/day group, with pain scores decreasing more in the Gabapentin group. The x-axis shows weeks from baseline to 8, and the y-axis shows mean pain scores from 0 to 10. Two study phases indicated: 4-week dose titration period and 4-week fixed dose period.*

FDA Label Image

Fig 2

A line graph titled 'Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2' showing mean pain scores on the y-axis and weeks on the x-axis. It compares pain scores over a 7-week period for placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day groups. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period, illustrating a decrease in mean pain scores for both gabapentin doses compared to placebo.*

FDA Label Image

Fig 3

A bar chart titled 'Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) doses across two studies. The chart shows higher response rates for gabapentin groups (3600 mg, 1800 mg, and 2400 mg) compared to placebo, with statistical significance indicated.*

FDA Label Image

Fig 4

A scatter plot showing responder rate differences (%) between gabapentin and placebo by daily dose (mg) in patients aged 12 years or older with partial seizures. The graph includes data points from three different studies labeled a, b, and c, illustrating variability in response rates across doses from 600 to 1800 mg.*

FDA Label Image

Formula

An equation diagram illustrating the formula for calculating creatinine clearance (CLCr), involving variables such as age, weight, sex adjustment factor, and serum creatinine level in mg/dl.*

FDA Label Image

Gabapentin 800mg Tab Qty 30 Ndc 80425 0158

Gabapentin 800 mg oral film-coated tablets, bottle label for 30 count from Advanced Rx Pharmacy of Tennessee, LLC. The label includes lot number, expiration date, NDC 80425-0158, storage instructions, and a QR code.*

FDA Label Image

Gabapentin 800mg Tab Qty 60 Ndc 80425 0158

The packaging label for Gabapentin 800 mg film coated tablets, quantity 60, from Advanced Rx Pharmacy of Tennessee, LLC. Includes lot number 60GAB8001221, expiration date 2/29/2024, storage instructions at room temperature 20°–25°C (68°–77°F), and a source NDC 65862-0524-05. The label also contains a QR code and a federal law caution regarding prescription use.*

FDA Label Image

Structure

Chemical structure of gabapentin, showing a cyclohexane ring attached to an amino methyl group and an acetic acid group, representing the molecular structure of the active ingredient gabapentin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.